tetano
Editor, Senior Moderator
Rev Med Virol
. 2021 Mar 16;e2189.
doi: 10.1002/rmv.2234. Online ahead of print.
Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus
Farzaneh Darbeheshti[SUP] 1 2 [/SUP], Mojdeh Mahdiannasser[SUP] 1 [/SUP], Bruce D Uhal[SUP] 3 [/SUP], Shuji Ogino[SUP] 4 5 6 [/SUP], Sudhir Gupta[SUP] 7 [/SUP], Nima Rezaei[SUP] 8 9 10 [/SUP]
Affiliations
Abstract
The coronavirus disease (Covid-19) pandemic is the most serious event of the year 2020, causing considerable global morbidity and mortality. The goal of this review is to provide a comprehensive summary of reported associations between inter-individual immunogenic variants and disease susceptibility or symptoms caused by the coronavirus strains severe acute respiratory syndrome-associated coronavirus, severe acute respiratory syndrome-associated coronavirus-2, and two of the main respiratory viruses, respiratory syncytial virus and influenza virus. The results suggest that the genetic background of the host could affect the levels of proinflammatory and anti-inflammatory cytokines and might modulate the progression of Covid-19 in affected patients. Notably, genetic variations in innate immune components such as toll-like receptors and mannose-binding lectin 2 play critical roles in the ability of the immune system to recognize coronavirus and initiate an early immune response to clear the virus and prevent the development of severe symptoms. This review provides promising clues related to the potential benefits of using immunotherapy and immune modulation for respiratory infectious disease treatment in a personalized manner.
Keywords: Covid-19; RSV; cytokine storm; genetic susceptibility; immune-related variants; influenza virus.
. 2021 Mar 16;e2189.
doi: 10.1002/rmv.2234. Online ahead of print.
Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus
Farzaneh Darbeheshti[SUP] 1 2 [/SUP], Mojdeh Mahdiannasser[SUP] 1 [/SUP], Bruce D Uhal[SUP] 3 [/SUP], Shuji Ogino[SUP] 4 5 6 [/SUP], Sudhir Gupta[SUP] 7 [/SUP], Nima Rezaei[SUP] 8 9 10 [/SUP]
Affiliations
- PMID: 33724604
- DOI: 10.1002/rmv.2234
Abstract
The coronavirus disease (Covid-19) pandemic is the most serious event of the year 2020, causing considerable global morbidity and mortality. The goal of this review is to provide a comprehensive summary of reported associations between inter-individual immunogenic variants and disease susceptibility or symptoms caused by the coronavirus strains severe acute respiratory syndrome-associated coronavirus, severe acute respiratory syndrome-associated coronavirus-2, and two of the main respiratory viruses, respiratory syncytial virus and influenza virus. The results suggest that the genetic background of the host could affect the levels of proinflammatory and anti-inflammatory cytokines and might modulate the progression of Covid-19 in affected patients. Notably, genetic variations in innate immune components such as toll-like receptors and mannose-binding lectin 2 play critical roles in the ability of the immune system to recognize coronavirus and initiate an early immune response to clear the virus and prevent the development of severe symptoms. This review provides promising clues related to the potential benefits of using immunotherapy and immune modulation for respiratory infectious disease treatment in a personalized manner.
Keywords: Covid-19; RSV; cytokine storm; genetic susceptibility; immune-related variants; influenza virus.